Healthcare Infection Control Practices Advisory Committee, (HICPAC), 63622-63623 [2011-26477]
Download as PDF
<![CDATA[
63622
Federal Register / Vol. 76, No. 198 / Thursday, October 13, 2011 / Notices
technique to produce full length clones
for the discovery of new genes without
polymerase chain reaction (PCR).
Both the Respondent and the U.S.
Public Health Service (PHS) are
desirous of concluding this matter
without further expenditure of time and
other resources and have entered into a
Voluntary Settlement Agreement to
resolve this matter. This settlement is
not an admission of liability on the part
of the Respondent.
Respondent and ORI agreed to settle
this matter as follows:
(1) Respondent agreed that for a
period of two (2) years beginning on
September 16, 2011, prior to the
submission of an application for PHS
support for a research project on which
her participation is proposed in a
research capacity, and prior to her
participation in this capacity on PHSsupported research, Respondent shall
ensure that a plan for supervising her
duties is submitted to ORI for approval;
the supervision must be designed to
ensure the scientific integrity of
Respondent’s research contribution;
Respondent agreed that she shall not
participate as a researcher in any PHSsupported research until such a
supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon supervision plan;
and
(2) Respondent agreed to exclude
herself from serving in any advisory
capacity to PHS including, but not
limited to, service on any PHS advisory
committee, board, and/or peer review
committee, or as a consultant, for a
period of two (2) years, beginning on
September 16, 2011.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Director, Division of Investigative Oversight,
Office of Research Integrity.
[FR Doc. 2011–26453 Filed 10–12–11; 8:45 am]
BILLING CODE 4150–31–P
sroberts on DSK5SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Biodefense
Science Board
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
SUMMARY:
VerDate Mar<15>2010
16:50 Oct 12, 2011
Jkt 226001
Department of Health and Human
Services is hereby giving notice that the
National Biodefense Science Board
(NBSB) will be holding a public meeting
via teleconference. The meeting is open
to the public.
DATES: The NBSB will hold a public
meeting on October 28, 2011 from 3
p.m. to 4 p.m. EST. The agenda is
subject to change as priorities dictate.
ADDRESSES: The meeting will occur by
teleconference. To attend, call 1–866–
395–4129, pass-code ‘‘ASPR.’’ Please
call 15 minutes prior to the beginning of
the conference call to facilitate
attendance. Individuals who wish to
participate should send an email to
NBSB@HHS.GOV with ‘‘NBSB
Registration’’ in the subject line.
FOR FURTHER INFORMATION CONTACT: Email: NBSB@HHS.GOV.
SUPPLEMENTARY INFORMATION: Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d–7f) and
section 222 of the Public Health Service
Act (42 U.S.C. 217a), the Department of
Health and Human Services established
the National Biodefense Science Board.
The Board shall provide expert advice
and guidance to the Secretary on
scientific, technical, and other matters
of special interest to the Department of
Health and Human Services regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate. The Board may also
provide advice and guidance to the
Secretary and/or the Assistant Secretary
for Preparedness and Response on other
matters related to public health
emergency preparedness and response.
Background: The majority of this
public meeting teleconference will be
dedicated to a discussion of the report
and recommendations from the NBSB’s
Anthrax Vaccine Working Group.
Subsequent agenda topics will be added
as priorities dictate. Any additional
agenda topics will be available on the
Board’s October meeting Web page prior
to the public meeting.
Availability of Materials: The meeting
agenda and materials will be posted
prior to the meeting on the October
meeting Web page at https://
www.phe.gov/preparedness/legal/
boards/nbsb/pages/default.aspx.
Procedures for Providing Public Input:
Members of the public are invited to
attend by teleconference via a toll-free
call-in phone number. The
teleconference will be operator assisted
to allow the public the opportunity to
provide comments to the Board. Public
participation will be limited to time and
space available. Public comments will
be limited to no more than 3 minutes
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
per speaker. To be placed on the public
comment list, notify the operator when
you join the teleconference.
Public comments received by close of
business one week prior to each
teleconference will be distributed to the
NBSB in advance. Submit comments via
email to NBSB@HHS.GOV, with ‘‘NBSB
Public Comment’’ as the subject line.
Dated: October 5, 2011.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2011–26389 Filed 10–12–11; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee, (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates:
9 a.m.–5 p.m., November 3, 2011.
9 a.m.–12 p.m., November 4, 2011.
Place: Embassy Suites-Washington, DC
Convention Center, Capital CD Room, 900
10th Street, NW., Washington, DC 2000.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at https://www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, the Director, National
Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), and the Director,
Division of Healthcare Quality Promotion
regarding (1) The practice of healthcare
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will
include updates on CDC’s activities for
healthcare associated infections, draft
guideline for prevention of infections among
patients in neonatal intensive care units
(NICU), draft guideline for infection control
in healthcare personnel, draft guideline for
the prevention of surgical site infections,
update from the HICPAC surveillance
working group, and guidance for control of
Carbapenem-resistant Enterobacteriaceae.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Heidi
Williams, HICPAC, Division of Healthcare
E:\FR\FM\13OCN1.SGM
13OCN1
Federal Register / Vol. 76, No. 198 / Thursday, October 13, 2011 / Notices
Quality Promotion, NCEZID, CDC, 1600
Clifton Road, NE., Mailstop A–07, Atlanta,
Georgia 30333, E-mail: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–26477 Filed 10–12–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
sroberts on DSK5SPTVN1PROD with NOTICES
Times and Dates
8:30 a.m.–4:30 p.m., November 3,
2011.
8:30 a.m.–12:30 p.m., November 4,
2011.
Place: CDC, 4770 Buford Highway,
Atlanta, Georgia 30341.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people.
Purpose: The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
and Administrator, NCEH/ATSDR, are
authorized under Section 301 (42 U.S.C.
241) and Section 311 (42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
VerDate Mar<15>2010
16:50 Oct 12, 2011
Jkt 226001
promotion of health and well being; and
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
mission to protect and promote people’s
health. The board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Matters To Be Discussed: The agenda
items for the BSC Meeting on November
3–4, 2011, will include NCEH/ATSDR
Office of the Director updates: ATSDR
and NCEH Reorganization; update on
Asthma, Lead and Healthy Homes
Program; presentation on public health
prioritization at ATSDR; update on the
Nutritional Biomarker Report: transfat
analysis; update on ATSDR Science
Symposium; update on Camp LeJeune;
update on Environmental Health
Tracking; presentation on hydraulic
fracking; global health updates: indoor
air pollution and health and lead in
Nigeria.
Agenda items are subject to change as
priorities dictate.
SUPPLEMENTARY INFORMATION: The
public comment period is scheduled on
Thursday, November 3, 2011 from 4:15
p.m. until 4:25 p.m., and Friday,
November 4, 2011, from 12:15 p.m. until
12:25 p.m.
Contact Person for More Information:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
4770 Buford Highway, Mail Stop F–61,
Chamblee, Georgia 30345; Telephone:
(770) 488–0575; Fax: (770) 488–3377; Email: smalcom@cdc.gov. The deadline
for notification of attendance is October
27, 2011.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: October 6, 2011.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2011–26501 Filed 10–12–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
63623
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
President’s Committee for People With
Intellectual Disabilities Committee
Meeting via Conference Call
President’s Committee for
People with Intellectual Disabilities
(PCPID), HHS.
ACTION: Notice of committee meeting via
conference call.
AGENCY:
Friday, October 28, 2011, from 1
p.m. to 2:30 p.m. EST. This meeting, to
be held via audio conference call, is
open to the public.
Details for accessing the full
Committee Conference Call, for the
public, are cited below:
Toll Free Dial-In Number: 888–282–
9630;
Pass Code: 9329684.
Individuals who will need
accommodations in order to participate
in the PCPID Meeting via audio
conferencing (assistive listening
devices, materials in alternative format
such as large print or Braille) should
notify Genevieve Swift, PCPID
Executive Administrative Assistant, at
Edith.Swift@acf.hhs.gov, or by
telephone at 202–619–0634, no later
than Friday, October 21, 2011. PCPID
will attempt to meet requests for
accommodations made after that date,
but cannot guarantee ability to grant
requests received after this deadline.
Agenda: Committee Members will
review and approve the 2011 PCPID
Report (Letter) to the President.
Additional Information: For further
information, please contact Laverdia
Taylor Roach, Senior Advisor,
President’s Committee for People with
Intellectual Disabilities, The Aerospace
Center, Second Floor West, 370 L’Enfant
Promenade, SW., Washington, DC
20447. Telephone: 202–619–0634. Fax:
202–205–9519. E-mail:
LRoach@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: PCPID
acts in an advisory capacity to the
President and the Secretary of Health
and Human Services, through the
Administration on Developmental
Disabilities, on a broad range of topics
relating to programs, services, and
supports for persons with intellectual
disabilities. The PCPID Executive Order
stipulates that the Committee shall: (1)
Provide such advice concerning
intellectual disabilities as the President
or the Secretary of Health and Human
Services may request; and (2) provide
advice to the President concerning the
DATES:
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 76, Number 198 (Thursday, October 13, 2011)]
[Notices]
[Pages 63622-63623]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-26477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee,
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Times and Dates:
9 a.m.-5 p.m., November 3, 2011.
9 a.m.-12 p.m., November 4, 2011.
Place: Embassy Suites-Washington, DC Convention Center, Capital
CD Room, 900 10th Street, NW., Washington, DC 2000.
Status: Open to the public, limited only by the space available.
Please register for the meeting at https://www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, the Director, National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), and the Director, Division of
Healthcare Quality Promotion regarding (1) The practice of
healthcare infection control; (2) strategies for surveillance,
prevention, and control of infections (e.g., nosocomial infections),
antimicrobial resistance, and related events in settings where
healthcare is provided; and (3) periodic updating of guidelines and
other policy statements regarding prevention of healthcare-
associated infections and healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on
CDC's activities for healthcare associated infections, draft
guideline for prevention of infections among patients in neonatal
intensive care units (NICU), draft guideline for infection control
in healthcare personnel, draft guideline for the prevention of
surgical site infections, update from the HICPAC surveillance
working group, and guidance for control of Carbapenem-resistant
Enterobacteriaceae.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Heidi Williams, HICPAC,
Division of Healthcare
[[Page 63623]]
Quality Promotion, NCEZID, CDC, 1600 Clifton Road, NE., Mailstop A-
07, Atlanta, Georgia 30333, E-mail: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: October 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-26477 Filed 10-12-11; 8:45 am]
BILLING CODE 4163-18-P
